Lantern Pharma
LTRN
LTRN
23 hedge funds and large institutions have $5.4M invested in Lantern Pharma in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $6.84M → $5.4M (-$1.45M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
23
Holding in Top 10
–
Calls
$43K
Puts
$2K
Top Buyers
| 1 | +$91.4K | |
| 2 | +$73K | |
| 3 | +$60.3K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$39.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$17.2K |
Top Sellers
| 1 | -$1.72M | |
| 2 | -$181K | |
| 3 | -$70K | |
| 4 |
WWM
Wolff Wiese Magana
Carslbad,
California
|
-$20.3K |
| 5 |
JPMorgan Chase & Co
New York
|
-$9K |